Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: recommendations from a European nursing task group.

Josephine Koldenhof

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number10.1016/j.ejon.2011.05.001
JournalEuropean Journal of Oncology Nursing
Volume2012
Issue numberapril
Publication statusPublished - Apr 2012

Cite this